TY - JOUR T1 - 105: Growth Analysis at Baseline in Children and Adolescents with Moderate-to-Severe Atopic Dermatitis Enrolled in Phase 3 Dupilumab Trials JO - Journal of Investigative Dermatology UR - https://doi.org/10.1016/j.jid.2025.02.110 PY - 2025/03/01 AU - Irvine AD AU - Paller AS AU - Siegfried EC AU - Cork MJ AU - Beck LA AU - Chen Z AU - Peralta C AU - Zhang A AU - Levy S AU - Cyr SL ED - DO - DOI: 10.1016/j.jid.2025.02.110 PB - Elsevier BV VL - 145 IS - 3 SP - e26 EP - e26 Y2 - 2025/04/10 ER -